Fentanyl Transdermal Patch and Mavacamten: Interaction Details
- Mavacamten
- Camzyos
- Fentanyl Transdermal Patch
- DuragesicAbstralSubsys +3 more
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Fentanyl Transdermal Patch and Mavacamten interaction:
Fentanyl Transdermal Patch
- Duragesic
- Abstral
- Subsys
- Ionsys
- Actiq
- Fentora
What Happens When You Take Fentanyl Transdermal Patch With Mavacamten
What can happen when they are taken together (rated Moderate)
Reduced exposure and reduced of CYP3A4 substrate
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
When mavacamten is given together with CYP3A4 substrates, exposure to those substrates may fall, and this may in turn lessen their efficacy. Close monitoring is therefore warranted during of mavacamten with CYP3A4 substrates.
A drug interaction study in healthy subjects evaluated a 16 day mavacamten regimen (25 mg on days 1 and 2, then 15 mg for the following 14 days) and found that midazolam (inf) was reduced by 13% and by 7%. For symptomatic obstructive hypertrophic cardiomyopathy (HCM) patients receiving once daily mavacamten at the upper end of the , predicted reductions in midazolam AUC(inf) and Cmax reach up to 45% and 24%, respectively.1
The Fentanyl Transdermal Patch and Mavacamten Interaction, Explained
Camzyos (mavacamten) is a heart medicine for obstructive hypertrophic cardiomyopathy. Fentanyl patches (Duragesic) are used for ongoing, severe pain. Your body breaks fentanyl down mostly with an enzyme called , and mavacamten may speed that enzyme up a little.
If that happens, less fentanyl may be in your blood, so the patch could work a bit less well and your pain might not be as controlled. This is mostly based on theory and on a study with a different drug (midazolam), where the effect was small. Please keep using both as prescribed. Tell your pharmacist or doctor if your pain seems to return or worsen. Your care team can watch you closely and adjust your treatment if needed.
Mechanism: Mavacamten may induce . Fentanyl is a CYP3A4 (active parent drug, not a ), so could lower fentanyl exposure and analgesic .
- Data: With midazolam, 16 days of mavacamten reduced (inf) by 13% and by 7%. Modeling predicts reductions up to 45% (AUC) and 24% (Cmax) at the upper in HCM patients.
- Evidence: Theoretical for fentanyl; no direct study. Onset unspecified.
- Management: Monitor closely for loss of analgesia or withdrawal symptoms. Fentanyl dose may need to be individualized. Be cautious if mavacamten is later stopped, as fentanyl exposure may rise again, so watch for and .
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Fentanyl Transdermal Patch and Mavacamten Interact
The likely mechanism
of -substrate by mavacamten
How to Manage the Fentanyl Transdermal Patch and Mavacamten Interaction
Your care team can manage this by monitoring you more closely.
- Keep using your fentanyl patch and Camzyos exactly as prescribed.
- Tell your pharmacist or prescriber if your pain control seems weaker than usual.
- Your fentanyl dose may need to be adjusted and individualized by your care team.
- Let them know about any changes to your Camzyos, since the effect on fentanyl could shift.
Do not change or stop either medicine on your own.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Fentanyl Transdermal Patch or Mavacamten need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: CAMZYOS oral capsules, mavacamten oral capsules
In a drug interaction study in healthy subjects, of a 16 day course of mavacamten (25 mg on days 1 and 2, then 15 mg for 14 days) lowered the (inf) and of midazolam by 13% and 7%, respectively. When mavacamten is given once daily to patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM) at the upper end of the , the AUC(inf) and Cmax of midazolam are predicted to fall by up to 45% and 24%, respectively.1
Fentanyl Transdermal Patch and Mavacamten: Common Questions
How serious is the Fentanyl Transdermal Patch and Mavacamten interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How is the Fentanyl Transdermal Patch and Mavacamten interaction managed?
Your care team can manage this by monitoring you more closely. Keep using your fentanyl patch and Camzyos exactly as prescribed. Tell your pharmacist or prescriber if your pain control seems weaker than usual. Your fentanyl dose may need to be adjusted and individualized by your care team. Let them know about any changes to your Camzyos, since the effect on fentanyl could shift. Do not change or s… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Fentanyl Transdermal Patch and Mavacamten Interaction
Ask in your own words about taking Fentanyl Transdermal Patch and Mavacamten together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: CAMZYOS(R) oral capsules, mavacamten oral capsules. Bristol-Myers Squibb Company (per Manufacturer), Princeton, NJ, 2025. DailyMed
Other Serious Interactions of Fentanyl Transdermal Patch and Mavacamten
Also serious with Mavacamten
- EncorafenibContraindicated
- MitapivatContraindicated
- Nafcillin InjectionContraindicated
- Amoxicillin / Omeprazole / RifabutinContraindicated
Also serious with Fentanyl Transdermal Patch
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Mavacamten
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- Vitamin EModerate
- GingerModerate
- TurmericModerate
- Black PepperModerate
- GrapeModerate
- + 140 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring. This interaction.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.